Cargando…
RTKN2 Inhibits the Growth, Migration, Invasion and Glycolysis of Lung Adenocarcinoma Cells by Inactivating the NF-κB Signalling Pathway
BACKGROUND: Lung adenocarcinoma (LUAD) is a malignant tumour that seriously threatens the life and health of people worldwide. This research was carried out to investigate the role of Rhotekin 2 (RTKN2) in LUAD progression. METHODS AND RESULTS: The GEPIA online database was used to analyse abnormall...
Autores principales: | Wang, Na, Wang, Jinxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10517892/ https://www.ncbi.nlm.nih.gov/pubmed/36952123 http://dx.doi.org/10.1007/s10528-023-10352-6 |
Ejemplares similares
-
Functional Variants in NFKBIE and RTKN2 Involved in Activation of the NF-κB Pathway Are Associated with Rheumatoid Arthritis in Japanese
por: Myouzen, Keiko, et al.
Publicado: (2012) -
RTKN2 is Associated with Unfavorable Prognosis and Promotes Progression in Non-Small-Cell Lung Cancer
por: Ji, Lupeng, et al.
Publicado: (2020) -
Down-Regulation of AHNAK2 Inhibits Cell Proliferation, Migration and Invasion Through Inactivating the MAPK Pathway in Lung Adenocarcinoma
por: Wang, Dong-Wei, et al.
Publicado: (2020) -
4‑Methoxydalbergione inhibits esophageal carcinoma cell proliferation and migration by inactivating NF‑κB
por: Li, Ming, et al.
Publicado: (2023) -
PAD4 silencing inhibits inflammation whilst promoting trophoblast cell invasion and migration by inactivating the NEMO/NF-κB pathway
por: Zeng, Min, et al.
Publicado: (2022)